A strong follow‑up from Chief Transformation & Growth Officer Simon Goeller on the strategic importance of Europe’s last fully integrated penicillin production site in Kundl, Austria. In his second interview on this topic, he reinforces why preserving this end‑to‑end manufacturing capability is vital for Europe’s security of supply and long‑term resilience - capacity that cannot be quickly rebuilt once lost. He also raises a central question: How should Europe balance security of supply and sustainability in antibiotics?
Europe’s last strategic penicillin asset: Kundl Europe today has only one fully integrated penicillin production site remaining — in Kundl, Austria — covering fermentation, active ingredient production and finished dosage forms under one roof. Across NATO and NATO Partnership for Peace territory, this is the last large-scale end-to-end facility of its kind. That makes it more than an industrial site. It is a strategic capability. Once such infrastructure is lost, rebuilding it takes years. In a crisis, years are not available. In this interview, I share why preserving existing manufacturing capacity in Europe is essential for long-term resilience. What do you think? How should Europe balance security of supply and sustainability in antibiotics? I’d love your perspective in the comments.